These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28955416)

  • 1. Monotherapy with amlodipine or hydrochlorothiazide in patients with mild to moderate hypertension: Comparison of their efficacy and effects on electrolytes.
    Nwachukwu DC; Eze AA; Nwachukwu NZ; Aneke EI; Agu PU; Azubike NC; Obika LF; Okoye OI
    Malawi Med J; 2017 Jun; 29(2):108-112. PubMed ID: 28955416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
    McGill JB; Reilly PA
    Clin Ther; 2001 Jun; 23(6):833-50. PubMed ID: 11440284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of amlodipine camsylate/losartan 5/100-mg versus losartan/hydrochlorothiazide 100/12.5-mg fixed-dose combination in hypertensive patients nonresponsive to losartan 100-mg monotherapy.
    Suh SY; Ahn T; Bae JH; Lim DS; Lee SU; Kim YK; Hyon MS; Kim WH; Han KR; Park HK
    Clin Ther; 2014 Oct; 36(10):1402-11. PubMed ID: 25146365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Hibiscus sabdariffaon blood pressure and electrolyte profile of mild to moderate hypertensive Nigerians: A comparative study with hydrochlorothiazide.
    Nwachukwu DC; Aneke E; Nwachukwu NZ; Obika LF; Nwagha UI; Eze AA
    Niger J Clin Pract; 2015; 18(6):762-70. PubMed ID: 26289514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, randomized double-blind study of valsartan/hydrochlorothiazide combination versus amlodipine in patients with mild to moderate hypertension.
    Palatini P; Malacco E; Fogari R; Carretta R; Bonaduce D; Bertocchi F; Mann J; Condorelli M;
    J Hypertens; 2001 Sep; 19(9):1691-6. PubMed ID: 11564991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR;
    Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term open evaluation of amlodipine vs hydrochlorothiazide in patients with essential hypertension.
    Adolphe AB; Vlachakis ND; Rofman BA; Brescia D; Zellner SR
    Int J Clin Pharmacol Res; 1993; 13(4):203-10. PubMed ID: 8150546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension.
    Lacourcière Y; Poirier L; Lefebvre J; Archambault F; Cléroux J; Boileau G
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1154-9. PubMed ID: 8998248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension.
    Oparil S; Barr E; Elkins M; Liss C; Vrecenak A; Edelman J
    Clin Ther; 1996; 18(4):608-25. PubMed ID: 8879890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.
    Calhoun DA; Lacourcière Y; Chiang YT; Glazer RD
    Hypertension; 2009 Jul; 54(1):32-9. PubMed ID: 19470877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial.
    Sohn IS; Kim CJ; Oh BH; Hong TJ; Park CG; Kim BS; Chung WB;
    Am J Cardiovasc Drugs; 2016 Apr; 16(2):129-38. PubMed ID: 26691333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of valsartan/hydrochlorothiazide and amlodipine on ambulatory blood pressure and plasma norepinephrine levels in high-risk hypertensive patients.
    Malacco E; Piazza S; Scandiani L; Zoppi A
    Adv Ther; 2004; 21(3):149-61. PubMed ID: 15509131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
    Punzi HA
    Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):12-21. PubMed ID: 24492985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and effects on lipid metabolism of combination treatment with losartan + hydrochlorothiazide versus losartan + amlodipine: a 48-week prospective, multicenter, randomized, open-label trial.
    Nishiwaki M; Hosoai H; Ikewaki K; Ayaori M; Yamashita T; Shige H; Higashi K; Nashida Y; Shimizu S; Kijima F; Yokoyama M; Nakamura H;
    Clin Ther; 2013 Apr; 35(4):461-73. PubMed ID: 23490288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of triple combination therapy with azilsartan/amlodipine/hydrochlorothiazide on office/home blood pressure: a randomized-controlled trial in Japanese essential hypertensive patients.
    Rakugi H; Shimizu K; Sano Y; Nishiyama Y; Kinugawa Y; Terashio S
    Blood Press Monit; 2018 Apr; 23(2):91-102. PubMed ID: 29239867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J; Shojaee A; Maa JF
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aliskiren/amlodipine vs. aliskiren/hydrochlorothiazide in hypertension: indirect meta-analysis of trials comparing the two combinations vs. monotherapy.
    Liu Y; Yan R; Song A; Niu X; Cao C; Wei J; Dong X; Gao D
    Am J Hypertens; 2014 Feb; 27(2):268-78. PubMed ID: 24304656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of valsartan/hydrochlorothiazide fixed-dose combination compared with amlodipine monotherapy as first-line therapy for mild to moderate hypertension.
    Chao CL; Lin YH; Lin LC; Lin LY; Tsai CT; Wang YC; Hwang JJ; Chen JC; Chiang FT
    J Int Med Res; 2009; 37(2):289-97. PubMed ID: 19383221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.